Camden National Corporation
NASDAQ:CACBanks - Regional
+$0.02 today
- Market cap
- $981.28M
- Beta
- 0.56
- P/E (TTM)
- 10.9
- EPS (TTM)
- $4.70
- Dividend yield
- 3.27%
Volume 0.06M
Average 0.10M
CAC Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Camden National CorporationNASDAQ: CAC
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was -$64.57M, compared with -$82.26M a year earlier.
Context
- Accumulated OCI amounted to 0.9% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
- Accumulated OCI grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +21.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (64.39M) USD
- Year-over-year change
- +32.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (64.39M) | +32.0% |
| FY2024 | 2024-12-31 | (94.65M) | +6.8% |
| FY2023 | 2023-12-31 | (101.55M) | +19.4% |
| FY2022 | 2022-12-31 | (125.96M) | -1922.1% |
| FY2021 | 2021-12-31 | (6.23M) | — |
Accumulated OCI vs competitors
How CAC compares with its peers on the latest reported figures
- CAC's Mar 2026 Accumulated OCI of -$64.57M is the 10th highest of the 11 companies compared; the peer median is -$24.11M.
- Its year-over-year change of +21.5% is the 7th highest of 11, against a peer median of +23.2%.
- Accumulated OCI amounts to 0.9% of total assets for CAC, versus a peer median of 0.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $255K | +108.8% | — | 0.0% | |
| Mar 2026 | -$5.7M | +25.1% | — | 0.2% | |
| Mar 2026 | -$9.97M | +35.8% | — | 0.4% | |
| Mar 2026 | -$13.43M | +21.3% | — | 0.6% | |
| Mar 2026 | -$23.46M | +33.6% | — | 0.7% | |
| Mar 2026 | -$24.76M | +24.3% | — | 0.8% | |
| Mar 2026 | -$31.94M | +16.7% | — | 1.9% | |
| Mar 2026 | -$34.27M | +6.1% | — | 0.4% | |
| Mar 2026 | -$42.23M | +22.1% | — | 2.3% | |
| Mar 2026 | -$64.57M | +21.5% | — | 0.9% | |
| Mar 2026 | -$78.44M | +20.9% | — | 1.2% | |
| Peer median (excluding CAC) | -$24.11M | +23.2% | — | 0.7% | |
Competitors are the stored peer set for CAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 220.63M | 75.43M | 99.8M | 214.96M | 97.49M |
| Short-term Investments | 1.51B | 695.88M | 625.81M | 577.79M | 930.4M |
| Net Receivables | 0 | 0 | 0 | 0 | 18.4M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | (5.24M) | (18.4M) |
| Total Current Assets | 1.73B | 771.3M | 725.61M | 787.51M | 1.03B |
| Property, Plant & Equipment (Net) | 37.78M | 36.02M | 35.05M | 37.05M | 0 |
| Goodwill | 94.7M | 94.7M | 94.7M | 94.7M | 151.51M |
| Intangible Assets | 2.19M | 1.56M | 971K | 415K | 42.58M |
| Long-term Investments | 3.41B | 4.53B | 4.62B | 4.63B | 5.44B |
| Tax Assets | 19.21M | 50.22M | 42.23M | 40.04M | 0 |
| Other Non-current Assets | 213.05M | 192.84M | 199.54M | 215.87M | (5.44B) |
| Total Non-current Assets | 3.77B | 4.9B | 4.99B | 5.02B | 194.09M |
| Total Assets | 5.5B | 5.67B | 5.71B | 5.81B | 6.97B |
| Account Payables | 94.23M | 84.14M | 92.14M | 0 | 0 |
| Short-term Debt | 211.61M | 265.18M | 485.61M | 500.62M | 581.78M |
| Tax Payables | 0 | 77.05M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.61B | 4.83B | 4.6B | 4.63B | 0 |
| Total Current Liabilities | 4.91B | 5.18B | 5.18B | 5.13B | 581.78M |
| Long-term Debt | 44.33M | 44.33M | 44.33M | 44.33M | 62.52M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 95.79M | 1.05B |
| Total Non-current Liabilities | 44.33M | 44.33M | 44.33M | 140.12M | 1.11B |
| Total Liabilities | 4.96B | 5.22B | 5.22B | 5.27B | 6.28B |
| Common Stock | 123.11M | 115.07M | 115.6M | 116.43M | 215.8M |
| Retained Earnings | 424.41M | 462.16M | 481.01M | 509.45M | 545.15M |
| Accumulated OCI | (6.23M) | (125.96M) | (101.55M) | (94.65M) | (64.39M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 541.29M | 451.28M | 495.06M | 531.23M | 696.56M |
| Total Debt | 255.94M | 309.51M | 529.94M | 544.95M | 644.3M |
| Net Debt | 35.31M | 234.08M | 430.13M | 329.99M | 546.8M |
Camden National Corporation
NASDAQ:CAC
Intrinsic Alpha fair value
Locked
Current Price
$58.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.